Objective: A secular trend toward earlier puberty onset in girls has been widely documented, with childhood overweight proposed as a contributing risk factor. This study aims to characterize body mass index (BMI) standard deviation score (SDS) trajectories over the 6 years preceding idiopathic central precocious puberty (CPP) onset in girls. Design and methods: This retrospective, single-center study included 460 girls diagnosed with idiopathic CPP at the Academic Children's Hospital Queen Fabiola between 2002 and 2022. The cohort was stratified into sporadic CPP, familial CPP, and CPP in internationally adopted girls. Clinical and demographic data were collected, and BMI trajectories were analyzed using piecewise mixed linear models. Pubertal onset (T0) was defined as Tanner stage B2. Results: Among the 460 cases, 285 (62%) were sporadic, 145 (31.5%) familial, and 30 (6.5%) adoption-related CPP. In addition, 11.7% were born small for gestational age (SGA). BMI SDS increased significantly during the 6 years preceding T0 across the entire cohort. The steepest rise occurred between 6 and 3 years before T0 (+0.21 SDS/year (95% CI: 0.13–0.29)), followed by a slower increase in the 3 years before T0 (+0.15 SDS/year (95% CI: 0.11–0.19)), and a subsequent stabilization post-T0 (+0.06 SDS/year (95% CI: −0.01–0.14)). The BMI increase rate was similar across all subgroups. Conclusions: Girls with idiopathic CPP show a significant prepubertal BMI SDS increase, with similar trajectories in sporadic and familial cases. The overrepresentation of SGA-born and adopted girls suggests that genetic and environmental factors may contribute to early pubertal onset. Plain language summary: This study is the first to track BMI trajectories up to 6 years before idiopathic CPP onset in girls, revealing an early rise in BMI SDS across all subgroups (sporadic, familial, and adopted girls). Notably, SGA-born and adopted girls showed similar BMI patterns but were overrepresented in this CPP cohort.
Invasive group A streptococcal (iGAS) infections are increasingly recognized as a global public health concern, with a notable resurgence observed among pediatric populations in high-income countries following the relaxation of COVID-19-related restrictions. While the most commonly implicated emm types in invasive disease are emm1 and emm3, the global distribution of Streptococcus pyogenes strains is highly diverse, posing challenges for surveillance and vaccine development. We describe a 3-year-old boy with a femoral subperiosteal abscess, a rare clinical manifestation of iGAS, caused by an emm6.10 S. pyogenes strain. The diagnosis was confirmed by positive blood cultures and magnetic resonance imaging. Antibiotic therapy included intravenous ceftriaxone followed by oral amoxicillin, and then prolonged oral clindamycin was introduced due to the deep-seated nature of the infection. Molecular typing was performed by the national reference center as part of routine surveillance of invasive strains. This case emphasizes the importance of recognizing atypical clinical presentations of iGAS in children and the crucial role of strain typing in epidemiological monitoring. It also illustrates how the remarkable emm-type diversity of S. pyogenes remains a major obstacle to effective vaccine design, despite ongoing efforts with multivalent M-protein-based candidates and alternative strategies targeting conserved antigens. Enhanced global surveillance and inclusive vaccine design are urgently needed to address the full spectrum of circulating GAS strains.
Background: C-reactive protein (CRP) is a readily available test widely used to assess neonatal sepsis (NS). In children with sepsis or other infectious conditions, CRP is more likely to be higher in females than males, however, evidence is lacking on sex differences in CRP in the neonatal population. This study aims to describe sex differences of CRP evolution in the ascending and decreasing phase after its peak in neonates with likely NS. Methods: This is a monocentric retrospective cohort study conducted at Etterbeek-Ixelles Hospital in Brussels. We included all neonates born in the facility between January 2017 and December 2022 who received antibiotics in the first 72 hours of life. Patients whose CRP concentrations remained under 10 mg/L were excluded. To describe the ascending kinetics of CRP and its logarithm for male and female neonates, we fitted a piecewise linear mixed-effects regression model with birth considered as time zero and one knot at 12 hours of life. We used a linear mixed-effects regression model with CRP peak considered as time zero to describe CRP’s descending kinetics and its logarithm for male and female neonates. Results: We included 506 neonates (60.1% male and 39.9% female). CRP concentration in the first 12 hours of life doubled every 3.2 and 2.8 hours, respectively, in males and females, with female neonates having a statistically significant faster rise of base 2 logarithm of CRP (+0.04 log2 mg/L/hour 95% CI= +0.01 +0.07). After 12 hours of life, CRP doubled every 6.5 and 8.6 hours, respectively, in males and females, with female neonates having a statistically significant slower rise of base 2 logarithm of CRP (-0.039 log2 mg/L/hour 95% CI= -0.02 -0.06). After its peak, CRP decreased by half every 31.1 and 30.9 hours, respectively, for males and females. No statistically significant sex differences were found in CRP peak or decline. Conclusion: In neonates of both sexes with likely but unconfirmed NS, CRP seems to increase, reach a peak, and then decrease, following a logarithmic pattern. Before antibiotic treatment, female neonates in our population showed an earlier increase in CRP levels, with no difference in peak CRP levels.
Introduction: Early-onset neonatal sepsis (EONS) requires rapid diagnosis, yet the interpretation of white blood cell (WBC) and absolute neutrophil count (ANC) is complicated by physiological postnatal changes. While sex differences in neutrophil responses are known in older populations, limited data exist in neonates. This study aimed to investigate the kinetics of WBC and ANC in neonates with likely EONS and evaluate potential sex differences, including responses to antibiotic initiation. Methods: We reviewed neonates treated at our center with antibiotics for likely EONS (suspected EONS with elevated CRP) between 2017 and 2022. WBC and ANC values were collected at standardized intervals before and after antibiotic initiation. Data were analyzed using piecewise linear mixed-effects regression models stratified by sex and timing of antibiotic initiation. Results: Of the 506 neonates included, 304 (60.1%) were males and 202 (39.9%) females. Female neonates had higher ANC at birth (10,366 vs. 9,573 cells/ μ L, p = 0.012) and after antibiotic initiation (14,519 vs. 13,359 cells/μL, p = 0.042). During the first 12 h of life, ANC increased in both sexes (673 cells/μL/hour in females, 603 cells/μL/hour in males, p = 0.001), with no difference in rate. Among neonates treated at birth, WBC counts increased more rapidly in females (557 vs. 380 cells/μL/hour, p = 0.020). In contrast, neonates treated after birth showed a similar decline in WBC and ANC regardless of sex. Conclusion: Female neonates with likely EONS consistently demonstrated higher ANC values and a more pronounced WBC increase in the early hours of life and after antibiotic initiation. This may reflect sex differences, potentially due to X-linked genes involved in the innate immune response. These findings support sex-specific interpretation of inflammatory markers in the evaluation of likely EONS evaluation and warrant further investigation into underlying immune differences.